These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34870897)

  • 41. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EAE of Mice: Enzymatic Cross Site-Specific Hydrolysis of H2B Histone by IgGs against H1, H2A, H2B, H3, and H4 Histones and Myelin Basic Protein.
    Urusov AE; Aulova KS; Dmitrenok PS; Buneva VN; Nevinsky GA
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
    al-Sabbagh A; Miller A; Santos LM; Weiner HL
    Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential levels of resistance to disease induction and development of relapsing experimental autoimmune encephalomyelitis in two H-2b-restricted mouse strains.
    Li J; Zhao X; Skoff R; Shaw MK; Tse HY
    J Neuroimmunol; 2011 May; 234(1-2):109-14. PubMed ID: 21482438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse.
    Shao H; Huang Z; Sun SL; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4060-5. PubMed ID: 15505056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
    Farooq SM; Elkhatib WF; Ashour HM
    Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis.
    Sosa RA; Murphey C; Ji N; Cardona AE; Forsthuber TG
    J Immunol; 2013 Dec; 191(12):5848-57. PubMed ID: 24227784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
    Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
    J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.
    Mangano K; Nicoletti A; Patti F; Donia M; Malaguarnera L; Signorelli S; Magro G; Muzio V; Greco B; Zaratin P; Meroni P; Zappia M; Nicoletti F
    Clin Exp Immunol; 2010 Feb; 159(2):159-68. PubMed ID: 19922500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
    Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
    J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.